Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
okn4395
Dedifferentiated Liposarcoma
EpkinP1CC (43)
okn4395
Gastric Adenocarcinoma
EpkinP1CC (43)
okn4395
Gastroesophageal Adenocarcinoma
EpkinP1CC (43)
okn4395
Leiomyosarcoma
EpkinP1CC (43)
okn4395
Myxofibrosarcoma
EpkinP1CC (43)
okn4395
Solitary Fibrous Tumor
EpkinP1CC (43)
okn4395
Undifferentiated Pleomorphic Sarcoma
EpkinP1CC (43)
Olaparib
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
Olaparib
Digestive System Cancer
M.D. Anderson Cancer CenterP1CC (43)
Olaparib
Male Reproductive Organ Cancer
M.D. Anderson Cancer CenterP1CC (43)
Olaparib
Malignant Endocrine Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Olaparib
Uterine Corpus Endometrial Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Olutasidenib
Chronic Myelomonocytic Leukemia
City of Hope Medical CenterP1CC (43)
Olverembatinib
Chronic Myeloid Leukemia
M.D. Anderson Cancer CenterP1CC (43)
Olverembatinib
Gastrointestinal Stromal Tumor
Ascentage Pharma Group Inc.P1CC (43)
Olverembatinib
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer CenterP1CC (43)
Olverembatinib
Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP1CC (43)
Omeprazole
Hodgkins Lymphoma
Murdoch Childrens Research InstituteP1CC (43)
Omeprazole
Developmental And Epileptic Encephalopathy, 14
Actio Biosciences, Inc.P1CC (43)
Omo-103
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP1CC (43)
Onabotulinum Toxin A
Hemorrhagic Stroke
University of AlbertaP1CC (43)
Onabotulinum Toxin A
Reversible Cerebral Vasoconstriction Syndrome
University of AlbertaP1CC (43)
Onabotulinum Toxin A
Stroke Disorder
University of AlbertaP1CC (43)
Onc 206
Anaplastic Astrocytoma
Jazz PharmaceuticalsP1CC (43)
Onc 206
Anaplastic Meningioma
Jazz PharmaceuticalsP1CC (43)
Showing 3601 to 3625 of 9,920 assets
PreviousPage 145 of 397Next